Study identifier:D133HR00041
ClinicalTrials.gov identifier:NCT06491862
EudraCT identifier:N/A
CTIS identifier:N/A
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer after failure of platinum-based chemotherapy in Brazil
Non-squamous Non-Small Cell Lung Cancer
N/A
No
-
All
250
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|